ACT-1002-4391

N/A

Report date: 2024/06/27 12:01:30
NMEFirst In Class

Base Information

Drug NameACT-1002-4391
Drug Alias NameACT-1002-4391OKN-4395OKN4395
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP2 receptor antagonistsProstanoid EP4 receptor antagonists
TargetsProstanoid EP2 receptorProstanoid EP4 receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIdorsia Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIdorsia Pharmaceuticals LtdOwkin Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A